BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 9, 2013
View Archived Issues
Novel small molecules useful as imaging tools in patients with cancer
Read More
Uncovering the antioxidative potential of paroxetine in hyperglycemic conditions
Read More
New CSF biomarker panel assay developed for the diagnosis of AD
Read More
Blood-based gene signature model for early detection of PD
Read More
Kowa and Daiichi Sankyo to end marketing partnership in Japan
Read More
AstraZeneca reports topline results from phase III fostamatinib study
Read More
Idenix Pharmaceuticals divulges novel agents for HCV infection
Read More
Canadian approval for Hologic's HPV assays
Read More
Emergent BioSolutions expands phase Ib study of TRU-016 with rituximab in CLL
Read More
ELOVL6 inhibitors suitable for treating insulin resistance
Read More
AC-708 described as CSF-1R inhibitor
Read More
Sanofi designs novel PKC-beta inhibitors
Read More
FDA approves Prolensa for postoperative inflammation and ocular pain
Read More
Ibrutinib receives third FDA breakthrough therapy designation
Read More
Roche and Isis Pharmaceuticals partner for Huntington's disease
Read More
Government of Japan, Gates Foundation and consortium of pharmaceutical companies launch partnership
Read More
Dainippon Sumitomo and Chugai agree to terminate joint development of anticancer vaccine candidates
Read More
Theratechnologies and Ferrer end tesamorelin agreement
Read More
Spectrum Pharmaceuticals commences phase II study of treatment for chemotherapy-induced neutropenia
Read More
Roche presents new aldosterone synthase inhibitors
Read More
DiaMedica cleared to conduct trial of lead diabetes treatment candidate
Read More
Anacor and Gates Foundation sign research agreement for neglected disease research
Read More
FDA approves Diclegis for morning sickness
Read More
Proximagen prepares new SSAO inhibitors
Read More
Glenmark Pharmaceuticals patents new MPGES-1 inhibitors
Read More
Crown Bioscience and Horizon Discovery sign new collaboration agreement
Read More